Injection

Prevention of Hepatitis A Virus Infection in the US: Recommendations of the ACIP

Jul 02, 2020 | Kimberly Sharpe-Scott

The CDC, in collaboration with the Advisory Committee on Immunization Practices (ACIP), published new recommendations for hepatitis A vaccination. The recently released MMWR, Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020, highlights the following key messages:

  • Hepatitis A vaccines were first recommended by ACIP in 1996 and the last full recommendations and report was published 14 years ago in 2006, when ACIP recommended routine hepatitis A vaccination of all children aged 12–23 months.
  • The hepatitis A virus (HAV) is transmitted via the fecal-oral route, usually through direct person-to-person contact or consumption of contaminated food or water.
  • Illness is usually mild and self-limited when healthy persons are infected, however disease severity increases in persons who are older or immunocompromised, have chronic liver disease, or have other underlying health conditions.
  • After the introduction of hepatitis A vaccination in 1996, reported hepatitis A cases fell over 95% between 1996 and 2011.
  • Since then small increases in cases occurred in 2013 and 2016 attributed to foodborne outbreaks associated with contaminated food; then, beginning in 2016, greater increases in the number of reported cases occurred across the United States, primarily from widespread outbreaks of hepatitis A from person-to-person transmission resulting in a sharp increase in cases from 2,007 in 2016 to 12,474 in 2018.
  • Low adult HepA vaccination coverage and high population susceptibility to HAV infection allow outbreaks to continue to occur.
  • These outbreaks have led the Advisory Committee on Immunization Practices to review the data on vaccination and prepare new hepatitis A recommendations to decrease HAV incidence and prevent future outbreaks.

The new and updated ACIP recommendations include, but are not limited to:

  • Vaccination of all children and adolescents aged 2–18 years who have not previously received HepA vaccine (catch-up vaccination)
  • Vaccination of all persons aged ≥1 year infected with human immunodeficiency virus (HIV)
  • Vaccination of pregnant women who are identified to be at risk for HAV infection during pregnancy or for having a severe outcome from HAV infection
  • Vaccination during hepatitis A outbreaks of persons aged ≥1 year who are at risk for HAV infection or who are at risk for severe disease from HAV
  • Vaccination in settings providing services to adults in which a high proportion of persons have risk factors for HAV infection (e.g., health care settings with a focus on those who use injection or non-injection drugs, group homes, and nonresidential day care facilities for developmentally disabled persons)

Access the recently released MMWR detailing updated hepatitis A vaccination recommendations here.


About Kimberly Sharpe-Scott

More posts by Kimberly Sharpe-Scott

Related Posts

I Stock 1262600344
  • Funding Opportunity
  • Health Equity & Social Justice
  • Opportunity
  • Training

Request for Proposals: Health Equity Symposium Meeting...

NACCHO, with support from the Centers for Disease Control and Prevention (CDC),...

Feb 07, 2023 | Ronique Taffe

Request for Proposals: Health Equity Symposium Meeting...

Boy after vaccine 1
  • Immunization

Updated National Immunization Assessment Data

In September 2022 and January 2023, the Centers for Disease Control and...

Feb 03, 2023 | Amiris Roberson

Updated National Immunization Assessment Data

SDOH Project Logo V2
  • Funding Opportunity
  • Community Health
  • Performance Improvement
  • Social Determinants of Health

RFP: Improving Social Determinants of Health – Getting...

Building upon the results of Years 1 and 2 of the CDC’s Improving Social...

Feb 03, 2023 | Andrea Grenadier

RFP: Improving Social Determinants of Health – Getting...

Microsoft Teams image
  • Community Health
  • Tuberculosis

CDC U.S. TB Elimination Champions Call for Nominations

Nominations for the U.S. CDC U.S. TB Elimination Champions are now open! CDC is...

Feb 01, 2023 | NacchoVoice, Irene Halferty

CDC U.S. TB Elimination Champions Call for Nominations

Microsoft Teams image
  • Webinar
  • Healthcare-Associated Infections
  • ID Featured
  • Infection, Prevention, and Control

Webinar: Tools to Address Multi-drug Resistant Organisms...

In this webinar, attendees had the opportunity to learn about the Council for...

Jan 24, 2023 | Irene Halferty

Webinar: Tools to Address Multi-drug Resistant Organisms...

I Stock 1202344480 1
  • Opioid Overdose Epidemic

The National Association of County and City Health...

The National Association of County and City Health Officials (NACCHO), along...

Jan 23, 2023

The National Association of County and City Health...

Outbreak Chart
  • Community Health
  • Infectious Disease
  • Opportunity

NACCHO Disease Outbreaks and Analytics Project Call for...

NACCHO is currently recruiting members for a community of practice focused on...

Jan 23, 2023 | NacchoVoice

NACCHO Disease Outbreaks and Analytics Project Call for...

Congress
  • Immunization

Inflation Reduction Act: Improving Adults Enrolled in...

In August 2022, the Biden Administration passed the Inflation Reduction Act...

Jan 17, 2023 | Victoria Thompson

Inflation Reduction Act: Improving Adults Enrolled in...

CIC Scholarship Canva Image
  • Funding Opportunity
  • Antibiotic Resistance
  • Community Health
  • Healthcare-Associated Infections

Scholarship Opportunity for Local Health Department...

Apply today! NACCHO is offering a scholarship opportunity for local health...

Jan 09, 2023 | Jaclyn Abramson

Scholarship Opportunity for Local Health Department...

Back to Top